申请人:DeVita Robert J.
公开号:US20140088124A1
公开(公告)日:2014-03-27
Described herein are compounds of formula (I), The compounds of formula I act as DGAT1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for hyperlipidemia, diabetes mellitus and obesity.
本文描述了化学式(I)的化合物。化合物I的作用是DGAT1抑制剂,可以用于预防,治疗或作为治疗高脂血症,糖尿病和肥胖症的药物。